CONMED Debt to Equity Ratio 2010-2024 | CNMD

Current and historical debt to equity ratio values for CONMED (CNMD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. CONMED debt/equity for the three months ending September 30, 2024 was 1.01.
CONMED Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $1.38B $0.93B 1.48
2024-06-30 $1.40B $0.88B 1.59
2024-03-31 $1.46B $0.86B 1.70
2023-12-31 $1.47B $0.83B 1.76
2023-09-30 $1.53B $0.80B 1.92
2023-06-30 $1.54B $0.78B 1.98
2023-03-31 $1.57B $0.75B 2.08
2022-12-31 $1.55B $0.75B 2.08
2022-09-30 $1.58B $0.72B 2.20
2022-06-30 $1.40B $0.67B 2.08
2022-03-31 $1.00B $0.79B 1.26
2021-12-31 $0.98B $0.79B 1.25
2021-09-30 $1.00B $0.76B 1.32
2021-06-30 $1.02B $0.74B 1.37
2021-03-31 $1.02B $0.73B 1.41
2020-12-31 $1.04B $0.71B 1.47
2020-09-30 $1.06B $0.68B 1.55
2020-06-30 $1.05B $0.68B 1.55
2020-03-31 $1.05B $0.70B 1.50
2019-12-31 $1.07B $0.71B 1.50
2019-09-30 $1.06B $0.70B 1.51
2019-06-30 $1.06B $0.70B 1.52
2019-03-31 $1.07B $0.69B 1.54
2018-12-31 $0.71B $0.66B 1.07
2018-09-30 $0.71B $0.65B 1.09
2018-06-30 $0.72B $0.65B 1.10
2018-03-31 $0.71B $0.64B 1.10
2017-12-31 $0.73B $0.63B 1.15
2017-09-30 $0.77B $0.59B 1.31
2017-06-30 $0.75B $0.58B 1.29
2017-03-31 $0.75B $0.58B 1.31
2016-12-31 $0.75B $0.58B 1.29
2016-09-30 $0.75B $0.58B 1.28
2016-06-30 $0.76B $0.58B 1.31
2016-03-31 $0.76B $0.58B 1.31
2015-12-31 $0.52B $0.59B 0.88
2015-09-30 $0.52B $0.58B 0.90
2015-06-30 $0.51B $0.58B 0.88
2015-03-31 $0.51B $0.57B 0.90
2014-12-31 $0.52B $0.58B 0.89
2014-09-30 $0.52B $0.59B 0.87
2014-06-30 $0.50B $0.60B 0.82
2014-03-31 $0.49B $0.60B 0.82
2013-12-31 $0.48B $0.61B 0.80
2013-09-30 $0.49B $0.59B 0.83
2013-06-30 $0.50B $0.59B 0.85
2013-03-31 $0.49B $0.60B 0.81
2012-12-31 $0.47B $0.61B 0.78
2012-09-30 $0.49B $0.60B 0.81
2012-06-30 $0.47B $0.59B 0.79
2012-03-31 $0.49B $0.59B 0.84
2011-12-31 $0.36B $0.57B 0.63
2011-09-30 $0.39B $0.61B 0.64
2011-06-30 $0.38B $0.62B 0.62
2011-03-31 $0.39B $0.60B 0.65
2010-12-31 $0.40B $0.59B 0.68
2010-09-30 $0.42B $0.58B 0.73
2010-06-30 $0.41B $0.58B 0.71
2010-03-31 $0.41B $0.58B 0.70
2009-12-31 $0.38B $0.58B 0.66
2009-09-30 $0.38B $0.57B 0.67
2009-06-30 $0.37B $0.56B 0.65
2009-03-31 $0.37B $0.56B 0.67
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.314B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.108B 21.59
Becton Dickinson (BDX) United States $64.746B 17.02
Cardinal Health (CAH) United States $29.487B 15.99
West Pharmaceutical Services (WST) United States $22.928B 46.83
Cooper (COO) United States $20.075B 28.58
Labcorp (LH) United States $20.046B 16.62
Align Technology (ALGN) United States $16.863B 32.27
Henry Schein (HSIC) United States $9.361B 17.83
Merit Medical Systems (MMSI) United States $6.139B 31.35
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
Patterson (PDCO) United States $1.803B 9.52
STAAR Surgical (STAA) United States $1.315B 48.51
Lifevantage (LFVN) United States $0.178B 23.67
Pro-Dex (PDEX) United States $0.152B 30.36